MYROBALAN THERAPEUTICS Trademark

Trademark Overview

On Friday, November 5, 2021, a trademark application was filed for MYROBALAN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MYROBALAN THERAPEUTICS trademark a serial number of 97111175. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Myro Therapeutics. The MYROBALAN THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum disorders, neuropathic pain, neuroinflammation diseases, neuroexcitation disorders, immunological disorders and cancers, the pharmaceutical preparations are not derived from or containing a component of the myrobalan tree

research and development of pharmaceutical preparations not derived from or containing a component of the myrobalan tree
myrobalan therapeutics

General Information

Serial Number97111175
Word MarkMYROBALAN THERAPEUTICS
Filing DateFriday, November 5, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum disorders, neuropathic pain, neuroinflammation diseases, neuroexcitation disorders, immunological disorders and cancers, the pharmaceutical preparations are not derived from or containing a component of the myrobalan tree
NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesresearch and development of pharmaceutical preparations not derived from or containing a component of the myrobalan tree

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMyro Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressArlington, MA 02476
Party NameMyro Therapeutics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArlington, MA 02476

Trademark Events

Event DateEvent Description
Tuesday, August 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 9, 2021NEW APPLICATION ENTERED
Tuesday, November 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Tuesday, August 16, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 16, 2022NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023NON-FINAL ACTION WRITTEN
Monday, April 10, 2023NON-FINAL ACTION E-MAILED
Monday, April 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 10, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, July 10, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, October 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 30, 2023NON-FINAL ACTION WRITTEN
Thursday, November 30, 2023NON-FINAL ACTION E-MAILED
Thursday, November 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 16, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 1 FILED
Tuesday, July 9, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

therapeutics myrobalan diseases disorders pharmaceutical preparations containing from derived component tree